KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Biomarin Pharmaceutical (BMRN) Shares Outstanding (2016 - 2022)

Historic Shares Outstanding for Biomarin Pharmaceutical (BMRN) over the last 14 years, with Q2 2022 value amounting to $185.5 million.

  • Biomarin Pharmaceutical's Shares Outstanding rose 116.24% to $185.5 million in Q2 2022 from the same period last year, while for Jun 2022 it was $185.5 million, marking a year-over-year increase of 116.24%. This contributed to the annual value of $183.9 million for FY2021, which is 119.51% up from last year.
  • Biomarin Pharmaceutical's Shares Outstanding amounted to $185.5 million in Q2 2022, which was up 116.24% from $184.9 million recorded in Q1 2022.
  • Biomarin Pharmaceutical's 5-year Shares Outstanding high stood at $185.5 million for Q2 2022, and its period low was $176.7 million during Q1 2018.
  • Its 5-year average for Shares Outstanding is $181.0 million, with a median of $181.0 million in 2020.
  • Per our database at Business Quant, Biomarin Pharmaceutical's Shares Outstanding soared by 193.24% in 2018 and then skyrocketed by 88.92% in 2019.
  • Quarter analysis of 5 years shows Biomarin Pharmaceutical's Shares Outstanding stood at $178.3 million in 2018, then increased by 0.89% to $179.8 million in 2019, then increased by 1.06% to $181.7 million in 2020, then grew by 1.2% to $183.9 million in 2021, then grew by 0.84% to $185.5 million in 2022.
  • Its Shares Outstanding was $185.5 million in Q2 2022, compared to $184.9 million in Q1 2022 and $183.9 million in Q4 2021.